Candace Y W Lee - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Candace Y W Lee

Showing results (1-10 of 9) with videos related to

Pageof 1

Sort By:

Heart Failure Reviews|April 19, 2007

Natriuretic peptides and therapeutic applicationsCandace Y W Lee, John C Burnett

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|January 23, 2009

Designer natriuretic peptidesCandace Y W Lee, Hsiao Lieu, John C Burnett

Reproductive Toxicology (Elmsford, N.Y.)|January 26, 2010

A pilot study of paternal drug exposure: the Motherisk experienceCandace Y W Lee, Cheng Jin, Andrea M Mata, et al.

The Canadian Journal of Cardiology|September 13, 2011

Digoxin toxicity precipitated by clarithromycin use: case presentation and concise review of the literatureCandace Y W Lee, François Marcotte, Geneviève Giraldeau, et al.

Journal of Clinical Pharmacology|April 28, 2009

Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjectsCandace Y W Lee, Horng H Chen, Ondrej Lisy, et al.

European Heart Journal. Cardiovascular Pharmacotherapy|June 25, 2016

Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actionsCandace Y W Lee, Brenda K Huntley, Daniel J McCormick, et al.

The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|January 7, 2010

Unusual reactions to 5-HT3 receptor antagonists in a child with rhabdomyosarcomaCandace Y W Lee, Savithiri Ratnapalan, Margaret Thompson, et al.

Clinical Pharmacology and Therapeutics|December 12, 2017

A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart FailureRika Kawakami, Candace Y W Lee, Christopher Scott, et al.

Plos One|January 7, 2017

Beneficial Effects of Reconstituted High-Density Lipoprotein (rHDL) on Circulating CD34+ Cells in Patients after an Acute Coronary SyndromeCatherine Gebhard, Eric Rhéaume, Colin Berry, et al.

Pageof 1

Search research articles

Showing results (1-10 of 9) with videos related to

Sort By:

Pageof 1

Heart Failure Reviews|April 19, 2007

Natriuretic peptides and therapeutic applicationsCandace Y W Lee, John C Burnett

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|January 23, 2009

Designer natriuretic peptidesCandace Y W Lee, Hsiao Lieu, John C Burnett

Reproductive Toxicology (Elmsford, N.Y.)|January 26, 2010

A pilot study of paternal drug exposure: the Motherisk experienceCandace Y W Lee, Cheng Jin, Andrea M Mata, et al.

The Canadian Journal of Cardiology|September 13, 2011

Digoxin toxicity precipitated by clarithromycin use: case presentation and concise review of the literatureCandace Y W Lee, François Marcotte, Geneviève Giraldeau, et al.

Journal of Clinical Pharmacology|April 28, 2009

Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjectsCandace Y W Lee, Horng H Chen, Ondrej Lisy, et al.

European Heart Journal. Cardiovascular Pharmacotherapy|June 25, 2016

Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actionsCandace Y W Lee, Brenda K Huntley, Daniel J McCormick, et al.

The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|January 7, 2010

Unusual reactions to 5-HT3 receptor antagonists in a child with rhabdomyosarcomaCandace Y W Lee, Savithiri Ratnapalan, Margaret Thompson, et al.

Clinical Pharmacology and Therapeutics|December 12, 2017

A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart FailureRika Kawakami, Candace Y W Lee, Christopher Scott, et al.

Plos One|January 7, 2017

Beneficial Effects of Reconstituted High-Density Lipoprotein (rHDL) on Circulating CD34+ Cells in Patients after an Acute Coronary SyndromeCatherine Gebhard, Eric Rhéaume, Colin Berry, et al.

Pageof 1